News
- May 21, 2020
Sussex Research / Queen’s University collaboration receives support to develop novel small molecule therapies for COVID-19
- August 22, 2018
Sussex Research / Queen’s University collaboration receives Collaborative Research and Development Grant (CRDPJ) to Develop Synthetic Strategies toward Deuterium-labeled pharmaceutical compounds with improved efficacy.
- October 13, 2017
Sussex Research Acquires Chemaphor Chemical Services from Avivagen
- September 21, 2017
Sussex Research Receives Notice of Allowance for Glycopeptide Cosmetic Active Technology Patent
- August 17, 2015
Sussex Research Announces Successful Clinical Trial Results for Glycolastin(TM) its Novel Anti-Aging Glycopeptide Cosmetic Active
- October 28, 2014
Sussex Research Presents Data on “Post Translationally Modified Cosmeceutical Actives” at the International Federation of Societies for Cosmetic Chemists (IFSCC) Congress in Paris
- September 5, 2014
Sussex Research Collaborator Receives Grant to Develop Glycan-Labelled BODIPY Fluorophores For Use In Glycobiology
- January 2, 2014
Pharmaceutical Technology Interviews Sussex Research CEO, Dr. Brady Clark, on the “Role of NMR and Mass Spectroscopy in Glycan Analysis.”
- December 12, 2013
Sussex Research Presents Data on “Post Translationally Modified Cosmeceutical Actives” at the Society for Cosmetic Chemists in New York
- January 17, 2012
Sussex Research Collaborator Receives Nserc Grant to Improve the Manufacture of Pseudaminic Acid
- May 25, 2010
Sussex Research Laboratories Appoints Wako Chemical Industries as a Distributor for its Carbohydrate-Based Products & Services in Japan
- June 25, 2007
Sussex Research Introduces Unique Sialic Acid-like Pseudaminic Acid Products for Research into Infectious Diseases
- November 1, 2005
Sussex Research and NRC Institute for Biological Sciences Form Glycobiology Product Research and Development Agreement
- April 1, 2003
Sussex Research Takes Occupancy in New NRC Industry Partnership Facility